serw-MX  [xml]  
 


    
 DeCS Categories

D26 Pharmaceutical Preparations .
D26.255 Dosage Forms .
D26.255.260 Drug Carriers .
E02 Therapeutics .
E02.319 Drug Therapy .
E02.319.267 Drug Administration Routes .
E02.319.300 Drug Delivery Systems .
E02.319.300.380 Drug Carriers .
E05 Investigative Techniques .
E05.916 Technology, Pharmaceutical .
E05.916.250 Dosage Forms .
G03 Metabolism .
G03.787 Pharmacokinetics .
G03.787.151 Biological Availability .
G07 Physiological Phenomena .
G07.690 Pharmacological and Toxicological Phenomena .
G07.690.725 Pharmacokinetics .
G07.690.725.129 Biological Availability .
VS2 Health Surveillance of Products .
VS2.002 Drug and Narcotic Control .
VS2.002.002 Chemical Industry .
VS2.002.002.001 Drug Industry .
VS2.002.002.001.001 Technology, Pharmaceutical .
VS2.002.002.001.001.005 Biological Availability .
VS2.002.002.001.001.010 Dosage Forms .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Drug Delivery Systems .
Delivery System, Drug .
Delivery Systems, Drug .
Drug Delivery System .
Drug Targetings .
System, Drug Delivery .
Systems, Drug Delivery .
Targeting, Drug .
Targetings, Drug .
Drug Targeting .
Systems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity. .
1.00
15148502
 
Dosage Forms .
Dosage Form .
Form, Dosage .
Forms, Dosage .
Completed forms of the pharmaceutical preparation in which prescribed doses of medication are included. They are designed to resist action by gastric fluids, prevent vomiting and nausea, reduce or alleviate the undesirable taste and smells associated with oral administration, achieve a high concentration of drug at target site, or produce a delayed or long-acting drug effect. .
0.42
965508
 
Drug Carriers .
Drug Carrier .
Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. .
0.42
4433118
 
Biological Availability .
Availability, Biologic .
Availability, Biological .
Availability, Physiologic .
Biologic Availability .
Availabilities, Biologic .
Availabilities, Biological .
Availabilities, Physiologic .
Availability Equivalencies .
Bioavailabilities .
Biologic Availabilities .
Biological Availabilities .
Equivalencies, Availability .
Equivalency, Availability .
Physiologic Availabilities .
Availability Equivalency .
Bioavailability .
Physiologic Availability .
The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. .
0.37
40235340
 
Drug Administration Routes .
Administration Routes, Drug .
Administration Route, Drug .
Drug Administration Route .
Route, Drug Administration .
Routes, Drug Administration .
The various ways of administering a drug or other chemical to a site in a patient or animal from where the chemical is absorbed into the blood and delivered to the target tissue. .
0.35
1055231